Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

WHAT'S NEW

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Apr 1 2021

Full Issue

Trump's Weak Initial Covid Response Prompted No-Bid Contracts

A congressional inquiry reveals Peter Navarro, a top aide to then-President Donald Trump, steered a $765 million loan to Eastman Kodak to produce ingredients for generic drugs, a $354 million sole-source contract for pharmaceutical ingredients to a start-up called Phlow, and a $96 million sole-source contract for powered respirators and filters from AirBoss Defense Group.

The Washington Post: Peter Navarro Warned Trump On Virus Supply Shortages, Then Pursued Deals Worth More Than $1 Billion

A top adviser privately urged President Donald Trump to acquire critical medical supplies in the early days of the coronavirus outbreak — and after the warning was ignored, pursued his own ad hoc strategy that committed more than $1 billion in federal funds and has since prompted multiple probes, according to newly released documents from congressional investigators. Peter Navarro, who served as Trump’s trade adviser, warned the president on March 1, 2020, to “MOVE IN ‘TRUMP TIME’” to invest in ingredients for drugs, handheld coronavirus tests and other supplies to fight the virus, according to a memo obtained by the House’s select subcommittee on the coronavirus outbreak. Navarro also said that he’d been trying to acquire more protective gear like masks, critiquing the administration’s pace. (Diamond, 3/31)

ProPublica: Documents Show Trump Officials Skirted Rules To Reward Politically Connected And Untested Firms With Huge Pandemic Contracts

Peter Navarro, who served as Trump’s deputy assistant and trade adviser, essentially verbally awarded a $96 million deal for respirators to a company with White House connections. Later, officials at the Federal Emergency Management Agency were pressured to sign the contract after the fact, according to correspondence obtained by congressional investigators. Documents obtained by the House Select Subcommittee on the Coronavirus Crisis after a year of resistance from the Trump administration offer new details about Navarro’s role in a largely secretive buying spree of personal protective equipment and medical supplies. (McSwane, 3/31)

Politico: House Panel Releases New Details Of Trump Administration Covid Contracts

A House panel investigating the coronavirus crisis released documents Tuesday detailing how senior White House officials tried to warn then-President Donald Trump of the danger of Covid-19 last March and leaned on federal agencies to offer non-competitive contracts for protective equipment to favored companies. The Select Subcommittee on the Coronavirus Crisis asked HHS, the Department of Homeland Security and the National Archives to turn over more records on the prior administration’s procurement of protective gear as part of an ongoing investigation. (Miranda Ollstein, 3/31)

In other news related to the previous administration —

The Washington Post: EPA Dismisses Dozens Of Key Science Advisers Picked Under Trump

Environmental Protection Agency Administrator Michael Regan will purge more than 40 outside experts appointed by President Donald Trump from two key advisory panels, a move he says will help restore the role of science at the agency and reduce the heavy influence of industry over environmental regulations. The unusual decision, announced Wednesday, will sweep away outside researchers picked under the previous administration whose expert advice helped the agency craft regulations related to air pollution, fracking and other issues. (Grandoni, 3/31)

AP: Reversing Trump, Pentagon Releases New Transgender Policies

The Pentagon on Wednesday swept away Trump-era policies that largely banned transgender people from serving in the military, issuing new rules that offer them wider access to medical care and assistance with gender transition. The new department regulations allow transgender people who meet military standards to enlist and serve openly in their self-identified gender, and they will be able to get medically necessary transition-related care authorized by law, chief Pentagon spokesman John Kirby told reporters during a briefing. (Baldor, 3/31)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF